3. Rajneesh C.P, Manimaran A., Sasikala K.R, Adaikappan P. Lipid peroxidation and antioxidant status in patients with breast cancer. Singapore Med. J. 2008. vol.49. P. 640-643.
4. Zowczak-Drabarczyk M.M,, Murawa D., Kaczmarek L., Polom K., Litwiniuk M. Total antioxidant status in plasma of breast cancer patients in relation to ERp expression. Contemp. Oncol. (Pozn). 2013. vol. 17. no 6. P. 499-503.
5. Kasapovic J., Pejic S., Todorovic A., Stojiljkovic V., Pajovic S.B. Antioxidant status and lipid peroxidation in the blood of breast cancer patients of different ages. Cell. Biochem Funct. 2008. vol. 26. P.723-730.
6. Rajneesh C.P., Manimaran A., Sasikala K.R., Adaikappan P. Lipid peroxidation and antioxidant status in patients with breast cancer. Singapore Med. J. 2008. vol.49. P.640-643.
7. Qebesy H.S., Zakhary M.M., Abd-Alaziz M. A., Abdel Ghany A.A., Maximus D. W. Tissue levels of oxidative stress markers and antioxidants in breast cancer patients in relation to tumor grade AAMJ. 2015. vol. 13, no 4. P. 10-17.
8. Франциянц Е.М., Солдаткина Н.В., Орловская Л.А., Дашков А.В. Некоторые показатели свободнорадикальных процессов и антиокислительной системы ткани опухоли молочной железы и ее перифокальной зоны при различных вариантах течения рака // Тюменский медицинский журнал. 2010. № 3-4. С. 92-94.
9. Окрут И.Е., Конторщикова К.Н., Шакерова Д.А. Клинико-лaбораторная оценка эндотелиальной дисфункции и активности свободнорадикального окисления при раке молочной железы // Медицинский альманах. 2012. № 2 (21). С. 68-70.
10. Chigh S., Ingram D., Hahnel R., Beilby J., Rossi E. Serum levels of micronutrients, antioxidants and total antioxidant status predict risk of breast cancer in case control study. J. Nutr. 2002. Vol. 132. P. 3003-3006.
11. Rossner P., Terry M.B., Gammon M.D., Agrawal M., Zhang F.F., Ferris J.S., Teitelbaum S.L., Eng S.M., Gaudet M.M., Neugut A.I., Santella R.M. Plasma protein carbonyl levels and breast cancer risk. J. Cell. Mol. Med. 2007. vol. 11. no 5. P. 1138-1148.
12. Mannello F., Tonti G.A, Medda V. Protein oxidation in breast microenvironment: Nipple aspirate fluid collected from breast cancer women contains increased protein carbonyl concentration. Cell Oncol. 2009. Vol.31. no 5. P. 383-392.
13. Bratt D., Jethva Kh., Patel S., Zaveri M. Role of oxidative stress in breast cancer. Pharmacy and pharmaceutical sciences. 2016. vol. 5. no 11. P. 366-379.
14. Nourazarian A.R., Kangari P., Salmaninejad A. Roles of Oxidative Stress in the Development and Progression of Breast Cancer. Asian Pac. J. Cancer Prev. 2014. Vol. 5. no 12. P.
4745-4751.
15. Mencalha A., Jacob V.V., Cecchini R., Panis C. Mapping Oxidative Changes in Breast Cancer: Understanding the Basic to Reach the Clinics. Anticancer Research. 2014 vol. 34 no. 3.
P. 1127-1140.
16. Hecht F., Pessoa C.F., Gentile L.B., Rosenthal D., Carvalho D.P, Fortunato R.S. The role of oxidative stress on breast cancer development and therapy. Tumour Biol. 2016. Vol.37. no 4. P. 4281-4291.
17. Shaw P.G., Chaerkady R., Wang T., Vasilatos S., Huang Y., van Houten B., Pandey A, Davidson N.E. Integrated proteomic and metabolic analysis of breast cancer progression. PLoS 2013. ONE 8 (9). Р. e76220.
18. Gorrini C., Harris I.S., Mak T.W. Modulation of oxidative stress as an anticancer strategy. Nat.Rev Drug Discov. 2013. vol. 12. no 12. P. 931-947.
19. Jezierska-Drutel A., Rosenzweig S.A., Neumann C.A. Role of Oxidative Stress and the Microenvironment in Breast Cancer Development and Progression. Adv. Cancer Res. 2013. vol.119: P.107-125.
20. Gurer-Orhan H, Ince E, Konyar D, Saso L, Suzen S. The Role of Oxidative Stress Modulators in Breast Cancer. Curr. Med. Chem. 2018. no.25(33). P. 4084-4101.
21. Tong L., Chuang C.C, Wu S., Zuo L. Reactive oxygen species in redox cancer therapy. Cancer Lett. 2015. vol. 10. No 367(1). P.18-25.
22. Vera-Ramirez L., Sanchez-Rovira P., Ramirez-Tortosa M.C., Ramirez- Tortosa C.L., Granados-Principal S., Lorente J.A., Quiles J.L. Free radicals in breast carcinogenesis, breast cancer progression and cancer stem cells. biological bases to develop oxidative-based therapies. Crit. Rev. in Oncol. Hematol. 2011. Vol. 80. P. 347-368.
23. Яковлев А.Ю., Улитин Д.Н., Чичканова А.С., Воронцов А.Ю. Профилактика метаболических осложнений адъювантной химиотерапии рака молочной железы // Онкология. Журнал им. П.А. Герцена. 2016. 5(3). С.44-49.
24. Бондаренко И.Н., Прохач А.В. Роль антиоксидантной терапии в процессе системного лечения рака молочной железы // Вестник проблем биологии и медицины. 2015. вып.4. Т. 2 (125). С.9-15.